These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2005-003813-33||Effects of Adrenaline on gastric tube blood flow in patients having thoracic epidural for Oesophagogastrectomy||2007-03-26||due-trials|
|Other||2009-011175-70||A randomised factorial trial of N-acetylcysteine prophylaxis and iso-osmolar versus low-osmolar contrast media on kidney function in patients at risk of contrast induced nephropathy following cardiac ...||not-yet-due|
|Reported results||2009-015800-25||A pilot randomised control trial, in intensive care patients, comparing seven days versus two days treatment with empirical antibiotics to treat hospital acquired infection of unknown origin||2011-07-31||due-trials|
|Not reported||2011-005273-23||HEAT-PPCI - How Effective are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention - A randomised controlled trial to compare unfractionated heparin versus bivalirudin in the treatme...||2018-12-17||due-trials|
|Other||2012-002880-86||PRESERVING ΒETA-CELLS: ‘RESTING THE PANCREAS’ IN CYSTIC FIBROSIS||not-yet-due|
|Not reported Terminated||2013-001447-31||A randomised controlled trial to study the effect of acetazolamide on the incidence of blood-stained CSF, effect on cerebrospinal fluid (CSF) pressure, CSF drainage and neurological dysfunction in pat...||2018-03-07||due-trials|
|Other||2015-003260-37||Can Ivabradine attenuate post-revascularisation microcirculatory dysfunction in flow limiting coronary artery disease?||not-yet-due|
|Reported results||2016-002832-34||Aztreonam for inhalation for the treatment of acute exacerbations in cystic fibrosis. An open-label, randomised, cross-over pilot study of AZLI plus intravenous Colistin versus standard dual intraveno...||2019-09-27||due-trials|